Latest Breaking News On - Alzheimer disease program - Page 3 : comparemela.com

ProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent Highlights

ProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent Highlights
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesAlzheimer disease programDrug administrationPromis neurosciences incCompany phaseExchange commissionGail farfelChief executive officerDisease programInvestigational new drugAnnual meetingNasdaq capital marketCollective coordinatesDisease specific epitopesAnnual report

ProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent Highlights

ProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent Highlights
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomPromis neurosciences incDrug administrationCompany phaseAlzheimer disease programExchange commissionGail farfelChief executive officerDisease programInvestigational new drugAnnual meetingNasdaq capital marketCollective coordinatesDisease specific epitopesAnnual report

Vaccinex Reports First Quarter 2023 Financial Results and Provides Corporate Update

Vaccinex Reports First Quarter 2023 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMaurice zaudererAlbertd friedbergVaccinex rochesterBrian czernieckiJohn mullalyHyos hanMerck sharp dohme corpAlzheimer disease programCo incMerck coVaccinex incMerck kgaaMoffitt cancer centerPfizer incPlatform technology

PRESSWIRE 2022/2023: ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent Highlights

TORONTO, Ontario and CAMBRIDGE, Massachusetts - - ProMIS Neurosciences Inc. , a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded. | May 16, 2023

United statesUnited kingdomSuzanne messereJohanne kaplanDrug development summitAlzheimer disease programPromis neurosciences incInternational conference on alzheimerAmerican academy of neurologyExchange commissionToronto stock exchangeDrug administrationChief executive officerDisease programInvestigational new drugRelated neurological disorders

Vaccinex Reports First Quarter 2023 Financial Results and Provides Corporate Update

Significant YTD Progress in Neurology and Oncology Programs New financing of $5MM closed without warrants, derivatives or other financial considerations ROCHESTER, N.Y., May 15, 2023 Vaccinex,. | May 15, 2023

United statesHyos hanBrian czernieckiAlbertd friedbergMaurice zaudererVaccinex rochesterJohn mullalyPfizer incMerck kgaVaccinex incCo incDevelopment expensesExchange commissionMerck kgaaLifesci advisorsMoffitt cancer center